(Q50513362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

title

Learning from PD-1 Resistance: New Combination Strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

3

Gordon J Freeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Xia Bu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Kathleen M Mahoney

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

publication date

9 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

Trends in Molecular Medicine

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

448-451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

4 April 2020

cites work

1 reference

12 December 2020

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

12 December 2020

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

1 reference

12 December 2020

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

1 reference

12 December 2020

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

1 reference

12 December 2020

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

1 reference

12 December 2020

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

1 reference

12 December 2020

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

1 reference

12 December 2020

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

1 reference

12 December 2020

10.1016/J.MOLMED.2016.04.008

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27174038%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference